FRCS (ORL-HNS) · SECTION 1 SBA

Allergic fungal rhinosinusitis

An immunocompetent young adult has chronic unilateral proptosis. CT shows expansile heterogeneously hyperdense sinus opacification with smooth bony remodelling; MRI shows central T2 signal loss. There is nasal polyposis and eosinophilic mucin but no tissue invasion. What is the best management?

CHOOSE ONE ANSWER

Best of five

  1. A. Endoscopic clearance and ventilation followed by topical anti-inflammatory treatment and surveillance
  2. B. Radical maxillectomy for invasive malignancy
  3. C. Systemic amphotericin as sole treatment
  4. D. No treatment because the patient is immunocompetent
  5. E. Orbital exenteration
ANSWER AND REASONING

A. Endoscopic clearance and ventilation followed by topical anti-inflammatory treatment and surveillance

The pattern supports allergic fungal rhinosinusitis, a non-invasive inflammatory disease. Surgery removes obstructive allergic mucin and restores access for topical corticosteroid therapy; recurrence surveillance is essential.

Why every option is right or wrong

A. Endoscopic clearance and ventilation followed by topical anti-inflammatory treatment and surveillance: The pattern supports allergic fungal rhinosinusitis, a non-invasive inflammatory disease. Surgery removes obstructive allergic mucin and restores access for topical corticosteroid therapy; recurrence surveillance is essential.

B. Radical maxillectomy for invasive malignancy: Smooth remodelling and absence of tissue invasion do not justify oncological resection.

C. Systemic amphotericin as sole treatment: This is not acute invasive fungal disease, and medication alone does not clear impacted mucin.

D. No treatment because the patient is immunocompetent: Non-invasive disease can still expand, erode bone and threaten the orbit.

E. Orbital exenteration: There is no invasive orbital fungal necrosis or malignant invasion.

What if the scenario changed?

If biopsy demonstrated angioinvasion with necrosis in a neutropenic patient, urgent radical debridement plus systemic antifungal treatment would be required.

EDUCATIONAL USE

Independent Clinora educational material; not official JCIE content, an accredited programme, clinical advice, or a substitute for local policy and specialist judgement.

Back to the Section 1 bank